Germany· DE-A57-d5e2d16a7d25260b
Kolipas Homöopathisches Arzneimittel Bei Erkrankungen Der Verdauungsorgane
A medicinal product containing chamomilla dil. d2, cuprum arsenicosum dil. d8, magnesium phosphoricum dil. d10, registered in Germany by Pascoe Pharmazeutische Präparate Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Chamomilla Dil. D2, Cuprum Arsenicosum Dil. D8, Magnesium Phosphoricum Dil. D10
- Manufacturer
- Pascoe Pharmazeutische Präparate Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ce88b3bb-656e-4697-8537-897da88408db GET /v1/drugs/ce88b3bb-656e-4697-8537-897da88408db?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Chamomilla Dil. D2, Cuprum Arsenicosum Dil. D8, Magnesium Phosphoricum Dil. D10",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about chamomilla dil. d2, cuprum arsenicosum dil. d8, magnesium phosphoricum dil. d10.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.